Reckitt Benckiser Group plc (the "Company" or "RB") announces the following change in the interests of a Director in ordinary shares of 10 pence each in the share capital of the Company ("Shares").
The Company was notified on 23 October 2019 that Sara Mathew, Non-Executive Director, purchased a total of 378 American Depositary Receipts in the Company (ADRs) on 23 October 2019 at a price of $15.46 each. Five ADRs represent one Share.
The remuneration of RB's Non-Executive Directors includes fees which are to be used in the purchase of Shares or equivalent, e.g. ADRs. £16,750 of the Non-Executive Directors' base fee (net) is invested in Shares or equivalent which they are expected to retain for the duration of their tenure. The amount of Sara Mathew's fees applied in this way were pro-rated based on her appointment to the Board on 1 July 2019.
The following disclosures are made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
Details of the person discharging managerial responsibilities / person closely associated
Reason for the notification
Initial notification/ Amendment
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Reckitt Benckiser Group plc
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument
American Depositary Receipts (each American Depositary Receipt is equivalent to five Ordinary shares of 10 pence each in Reckitt Benckiser Group PLC)
Nature of the transaction
Purchase of shares
Price(s) and volume(s)
- Aggregated volume
Date of the transaction
Place of the transaction
United States (OTC)
For further Information: Christine Logan
Deputy Company Secretary Tel +44 (0) 1753 217 800
SVP, Investor Relations
Tel. +44 (0)1753 217 800
Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108
RB* is a leading global health, hygiene and home company inspired by a vision of the world where people are healthier and live better. Its purpose is to make a difference by giving people innovative solutions for healthier lives and happier homes.
Through its two business units, Health and Hygiene Home, RB has operations in over 60 countries and its products reach millions of people globally every day. Its trusted household brands include names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite and Air Wick.
RB's drive to achieve, passion to outperform and commitment to quality and scientific excellence is manifested in the work of over 40,000 diverse, talented entrepreneurs worldwide.
For more information visit www.rb.com
*RB is the trading name of the Reckitt Benckiser group of companies
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
Create your account: sign up and get ahead on news and events
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...